solventum corp. - SOLV

SOLV

Close Chg Chg %
64.37 -0.81 -1.26%

Closed Market

63.56

-0.81 (1.26%)

Volume: 1.05M

Last Updated:

Apr 2, 2026, 3:59 PM EDT

Company Overview: solventum corp. - SOLV

SOLV Key Data

Open

$63.40

Day Range

62.67 - 64.49

52 Week Range

60.70 - 88.19

Market Cap

$11.03B

Shares Outstanding

173.49M

Public Float

147.59M

Beta

0.77

Rev. Per Employee

N/A

P/E Ratio

7.16

EPS

$8.93

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.46M

 

SOLV Performance

1 Week
 
1.29%
 
1 Month
 
-8.41%
 
3 Months
 
-19.55%
 
1 Year
 
-3.97%
 
5 Years
 
N/A
 

SOLV Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 15
Full Ratings ➔

About solventum corp. - SOLV

Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.

SOLV At a Glance

Solventum Corp.
3M Center
Maplewood, Minnesota 55144
Phone 1-651-733-1110 Revenue 8.33B
Industry Medical/Nursing Services Net Income 1.56B
Sector Health Services 2025 Sales Growth 0.86%
Fiscal Year-end 12 / 2026 Employees 20,000
View SEC Filings

SOLV Valuation

P/E Current 7.162
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 8.927
Price to Sales Ratio 1.669
Price to Book Ratio 2.723
Price to Cash Flow Ratio 37.64
Enterprise Value to EBITDA 15.116
Enterprise Value to Sales 2.193
Total Debt to Enterprise Value 0.287

SOLV Efficiency

Revenue/Employee 416,250.00
Income Per Employee 77,800.00
Receivables Turnover 7.031
Total Asset Turnover 0.579

SOLV Liquidity

Current Ratio 1.231
Quick Ratio 0.891
Cash Ratio 0.28

SOLV Profitability

Gross Margin 53.586
Operating Margin 8.637
Pretax Margin 20.577
Net Margin 18.691
Return on Assets 10.824
Return on Equity 38.861
Return on Total Capital 15.113
Return on Invested Capital 14.762

SOLV Capital Structure

Total Debt to Total Equity 103.922
Total Debt to Total Capital 50.962
Total Debt to Total Assets 36.708
Long-Term Debt to Equity 102.535
Long-Term Debt to Total Capital 50.282
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Solventum Corp. - SOLV

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
8.13B 8.20B 8.25B 8.32B
Sales Growth
-0.50% +0.82% +0.70% +0.86%
Cost of Goods Sold (COGS) incl D&A
3.44B 3.50B 3.64B 3.86B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
578.00M 561.00M 530.00M 489.00M
Depreciation
177.00M 164.00M 181.00M 177.00M
Amortization of Intangibles
401.00M 397.00M 349.00M 312.00M
COGS Growth
+5.76% +2.01% +3.94% +6.10%
Gross Income
4.70B 4.69B 4.61B 4.46B
Gross Income Growth
-4.63% -0.04% -1.73% -3.27%
Gross Profit Margin
+57.75% +57.25% +55.88% +53.59%
2022 2023 2024 2025 5-year trend
SG&A Expense
3.00B 3.00B 3.51B 3.74B
Research & Development
767.00M 758.00M 768.00M 727.00M
Other SG&A
2.23B 2.24B 2.75B 3.02B
SGA Growth
-1.38% -0.03% +17.09% +6.49%
Other Operating Expense
- - - -
-
Unusual Expense
- - 62.00M 169.00M
-
EBIT after Unusual Expense
1.69B 1.69B 1.04B 550.00M
Non Operating Income/Expense
(1.00M) (25.00M) (64.00M) 1.51B
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - 367.00M 347.00M
-
Interest Expense Growth
- - - -5.45%
-
Gross Interest Expense
- - 367.00M 347.00M
-
Interest Capitalized
- - - -
-
Pretax Income
1.69B 1.67B 605.00M 1.71B
Pretax Income Growth
-10.10% -1.48% -63.71% +183.14%
Pretax Margin
+20.81% +20.34% +7.33% +20.58%
Income Tax
349.00M 321.00M 126.00M 157.00M
Income Tax - Current - Domestic
408.00M 192.00M 137.00M 67.00M
Income Tax - Current - Foreign
82.00M 271.00M 144.00M 210.00M
Income Tax - Deferred - Domestic
(135.00M) (17.00M) (145.00M) 30.00M
Income Tax - Deferred - Foreign
(6.00M) (125.00M) (10.00M) (150.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
1.34B 1.35B 479.00M 1.56B
Minority Interest Expense
- - - -
-
Net Income
1.34B 1.35B 479.00M 1.56B
Net Income Growth
-8.01% +0.22% -64.41% +224.84%
Net Margin Growth
+16.52% +16.42% +5.80% +18.69%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
1.34B 1.35B 479.00M 1.56B
Preferred Dividends
- - - -
-
Net Income Available to Common
1.34B 1.35B 479.00M 1.56B
EPS (Basic)
7.7761 7.7934 2.7656 8.9374
EPS (Basic) Growth
-8.01% +0.22% -64.51% +223.16%
Basic Shares Outstanding
172.71M 172.71M 173.20M 174.10M
EPS (Diluted)
7.7761 7.7934 2.7576 8.8762
EPS (Diluted) Growth
-8.01% +0.22% -64.62% +221.88%
Diluted Shares Outstanding
172.71M 172.71M 173.70M 175.30M
EBITDA
2.27B 2.25B 1.63B 1.21B
EBITDA Growth
-8.28% -0.79% -27.74% -25.80%
EBITDA Margin
+27.93% +27.49% +19.72% +14.51%

Snapshot

Average Recommendation HOLD Average Target Price 88.00
Number of Ratings 15 Current Quarters Estimate 1.661
FY Report Date 06 / 2026 Current Year's Estimate 6.474
Last Quarter’s Earnings 1.352 Median PE on CY Estimate N/A
Year Ago Earnings 6.11 Next Fiscal Year Estimate 7.022
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 10 10 11 11
Mean Estimate 1.66 1.68 6.47 7.02
High Estimates 1.71 1.75 6.52 7.56
Low Estimate 1.60 1.56 6.33 6.57
Coefficient of Variance 2.01 3.39 0.84 3.76

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 7
OVERWEIGHT 0 0 0
HOLD 8 8 7
UNDERWEIGHT 0 0 1
SELL 2 2 1
MEAN Hold Hold Overweight

Solventum Corp. in the News